The global dental biomaterials market size is calculated at USD 10.26 billion in 2025 and is forecasted to reach around USD 18.4 billion by 2034, accelerating at a CAGR of 6.7% from 2025 to 2034. The North America dental biomaterials market size surpassed USD 3.66 billion in 2024 and is expanding at a CAGR of 6.73% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Dental Biomaterials Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Dental Biomaterials Market, by Type
8.1.1. Metallic Biomaterials
8.1.1.1. Market Revenue and Forecast
8.1.2. Ceramic Biomaterials
8.1.2.1. Market Revenue and Forecast
8.1.3. Polymeric Biomaterials
8.1.3.1. Market Revenue and Forecast
8.1.4. Metal-Ceramic Biomaterials
8.1.4.1. Market Revenue and Forecast
8.1.5. Natural Biomaterials
8.1.5.1. Market Revenue and Forecast
8.1.6. Composites Biomaterials
8.1.6.1. Market Revenue and Forecast
9.1. Dental Biomaterials Market, by Application
9.1.1. Implantology
9.1.1.1. Market Revenue and Forecast
9.1.2. Orthodontics
9.1.2.1. Market Revenue and Forecast
9.1.3. Prosthodontics
9.1.3.1. Market Revenue and Forecast
9.1.4. Others
9.1.4.1. Market Revenue and Forecast
10.1. Dental Biomaterials Market, by End Use Type
10.1.1. Dental Hospitals and Clinics
10.1.1.1. Market Revenue and Forecast
10.1.2. Dental Laboratories
10.1.2.1. Market Revenue and Forecast
10.1.3. Dental Academics and Research Institutes
10.1.3.1. Market Revenue and Forecast
10.1.4. Dental Product Manufacturers
10.1.4.1. Market Revenue and Forecast
11.1. Dental Biomaterials Market, by Bone Graft Material Type
11.1.1. Allograft
11.1.1.1. Market Revenue and Forecast
11.1.2. Xenograft
11.1.2.1. Market Revenue and Forecast
11.1.3. Synthetic
11.1.3.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Type
12.1.2. Market Revenue and Forecast, by Application
12.1.3. Market Revenue and Forecast, by End Use Type
12.1.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type
12.1.5.2. Market Revenue and Forecast, by Application
12.1.5.3. Market Revenue and Forecast, by End Use Type
12.1.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type
12.1.6.2. Market Revenue and Forecast, by Application
12.1.6.3. Market Revenue and Forecast, by End Use Type
12.1.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type
12.2.2. Market Revenue and Forecast, by Application
12.2.3. Market Revenue and Forecast, by End Use Type
12.2.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type
12.2.5.2. Market Revenue and Forecast, by Application
12.2.5.3. Market Revenue and Forecast, by End Use Type
12.2.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type
12.2.6.2. Market Revenue and Forecast, by Application
12.2.6.3. Market Revenue and Forecast, by End Use Type
12.2.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type
12.2.7.2. Market Revenue and Forecast, by Application
12.2.7.3. Market Revenue and Forecast, by End Use Type
12.2.7.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type
12.2.8.2. Market Revenue and Forecast, by Application
12.2.8.3. Market Revenue and Forecast, by End Use Type
12.2.8.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type
12.3.2. Market Revenue and Forecast, by Application
12.3.3. Market Revenue and Forecast, by End Use Type
12.3.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type
12.3.5.2. Market Revenue and Forecast, by Application
12.3.5.3. Market Revenue and Forecast, by End Use Type
12.3.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type
12.3.6.2. Market Revenue and Forecast, by Application
12.3.6.3. Market Revenue and Forecast, by End Use Type
12.3.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type
12.3.7.2. Market Revenue and Forecast, by Application
12.3.7.3. Market Revenue and Forecast, by End Use Type
12.3.7.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type
12.3.8.2. Market Revenue and Forecast, by Application
12.3.8.3. Market Revenue and Forecast, by End Use Type
12.3.8.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type
12.4.2. Market Revenue and Forecast, by Application
12.4.3. Market Revenue and Forecast, by End Use Type
12.4.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type
12.4.5.2. Market Revenue and Forecast, by Application
12.4.5.3. Market Revenue and Forecast, by End Use Type
12.4.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type
12.4.6.2. Market Revenue and Forecast, by Application
12.4.6.3. Market Revenue and Forecast, by End Use Type
12.4.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type
12.4.7.2. Market Revenue and Forecast, by Application
12.4.7.3. Market Revenue and Forecast, by End Use Type
12.4.7.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type
12.4.8.2. Market Revenue and Forecast, by Application
12.4.8.3. Market Revenue and Forecast, by End Use Type
12.4.8.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type
12.5.2. Market Revenue and Forecast, by Application
12.5.3. Market Revenue and Forecast, by End Use Type
12.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type
12.5.5.2. Market Revenue and Forecast, by Application
12.5.5.3. Market Revenue and Forecast, by End Use Type
12.5.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type
12.5.6.2. Market Revenue and Forecast, by Application
12.5.6.3. Market Revenue and Forecast, by End Use Type
12.5.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type
13.1. 3M Company
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bego Medical GmbH
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Carpenter Technology Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Danaher Corporation
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Datum Dental Ltd.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. GC Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Henry Schein Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. IvoclarVivadent AG
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Keystone Dental Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Medtronic PLC
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample